首页> 外文OA文献 >Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi
【2h】

Trypanosoma vivax is the second leading cause of camel trypanosomosis in Sudan after Trypanosoma evansi

机译:间日锥虫是继伊万氏锥虫后苏丹骆驼锥虫病的第二大诱因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: This study was conducted in response to recurring reports from eastern Sudan of camel trypanosomosis that can no longer be treated by currently available trypanocidal drugs. One hundred and eighty-nine blood samples were obtained from camels in different herds and local markets in the western part of Sudan, and a cross-sectional study was carried out between December 2015 and February 2016 to identify the causative agents and possible circulating genotypes. Results: The prevalence of trypanosomes detected using the conventional parasitological techniques of Giemsa-stained blood smears, wet blood smears and the microhematocrit centrifugation technique (MHCT) was 7% (13/189), 11% (21/189) and 19% (36/189), respectively. However, a multi-species KIN-PCR targeting the ITS region revealed that the prevalence of Trypanosoma evansi was 37% (70/189), while that of T. vivax was 25% (47/189). Consequently, we used a T. evansi-specific PCR (RoTat1.2 VSG gene) to analyse the KIN-PCR-positive samples and a T. vivax-specific PCR (Cathepsin L-like gene) to analyse all of the samples. The prevalence of T. evansi was 59% (41/70), while the prevalence of T. vivax was 31% (59/189). Mixed infections were detected in 18% (34/189) of the samples. These results were further confirmed by sequencing and a phylogenetic analysis of the complete internal transcribed spacer (ITS) region of T. evansi and the TviCatL gene of T. vivax. Conclusion: We conclude that T. vivax was newly introduced to the camel population and that T. evansi is no longer the single cause of camel trypanosomosis in Sudan. The presence of T. vivax in camels detected in this study is a challenge in the choice of diagnostic approaches, particularly serology, and PCRs. However, an analysis of drug resistance should be performed, and the genotypic variation should be verified. To our knowledge, this is the first molecular study on T. vivax and mixed-infection with T. vivax and T. evansi in Sudanese camels.
机译:背景:这项研究是针对苏丹东部关于骆驼锥虫病的重复报道而进行的,该报道不再可用当前可用的锥虫病药物治疗。从苏丹西部不同牧群和当地市场的骆驼中采集了189份血样,并于2015年12月至2016年2月进行了横断面研究,以确定病原体和可能的循环基因型。结果:使用吉姆萨染色的血涂片,湿血涂片和微血球比容离心技术(MHCT)的常规寄生虫学技术检测到的锥虫的流行率分别为7%(13/189),11%(21/189)和19%( 36/189)。然而,针对ITS区的多物种KIN-PCR显示伊万锥虫的患病率为37%(70/189),而间日疟原虫的患病率为25%(47/189)。因此,我们使用伊凡氏酵母特异性PCR(RoTat1.2 VSG基因)分析KIN-PCR阳性样品,而间日疟原虫特异性PCR(组织蛋白酶L样基因)分析所有样品。伊凡氏锥虫的患病率为59%(41/70),而间日疟原虫的患病率为31%(59/189)。在18%(34/189)的样本中检测到混合感染。这些结果通过对埃文氏螺旋体完整内部转录间隔区(ITS)和间日疟原虫TviCatL基因的测序和系统发育分析进一步证实。结论:我们得出的结论是,间日疟原虫是新引入骆驼种群的,伊文氏疟原虫不再是苏丹骆驼锥虫病的唯一原因。在这项研究中检测到的骆驼中存在间日疟原虫,这对选择诊断方法(尤其是血清学和PCR)是一个挑战。但是,应进行耐药性分析,并应验证基因型变异。据我们所知,这是关于苏丹骆驼中间日疟原虫和间日疟原虫和伊文氏疟原虫混合感染的第一个分子研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号